OATD-01

Phase 2Small molecule

UUnknown Sponsor

OATD-01 is one of 9 small molecule programs targeting Pulmonary Sarcoidosis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pulmonary SarcoidosisRecruiting

Pulmonary SarcoidosisPhase 2

Recruiting

Competition

Competitive Landscape

8 competitors in Pulmonary Sarcoidosis

#DrugCompanyPhaseTrials

Trexall

Jazz Pharmaceuticals

Approved

1 2

Nicorette

Plaquenil

Rayos

3 5

Deltasone

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

1 6

Efzofitimod

AaTyr Pharma, Inc.

Phase 3

1 7

XTMAB-16

XXentria, Inc.

Phase 2

2 8

Glucocorticoid

AbbVie

Preclinical

1 9

OATD-01

UUnknown Sponsor

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Phase 2Recruiting

Pulmonary Sarcoidosis

NCT06205121

Clinical

Trials by Indication[1]

Pulmonary Sarcoidosis1 trial

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a 12-week Administration of OATD-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis (the KITE Study)

Recruiting·UUnknown Sponsor·Phase 2·NCT06205121·96 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for OATD-01. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — OATD-01 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for OATD-01. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Unknown Sponsor company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUnknown Sponsor

OATD-01

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Pulmonary Sarcoidosis1 trial

References

Drug Info

Quick Facts

Related News